drugset / Trial / NCT01579383
Safety Tolerability and Pharmacokinetics of ALD403
RandomizedSingle-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the safety, tolerability and pharmacokinetics of ALD403, a monoclonal antibody, administered by intravenous infusion and subcutaneous injection.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-12
- Completion
- 2013-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eptinezumab | Monoclonal antibody | — | Intravenous |
| Subject | Sumatriptan | Unknown | — | Subcutaneous |